Senior Lecturer
The University of Sydney, Australia
Nick is a Senior Lecturer at the University of Sydney and the ANZAC Research Institute at Concord Hospital. His group develops nanotechnology platforms for the oral delivery of insulin without hypoglycaemia and immune modulation nanotechnologies for the prevention of type 1 diabetes without immune suppression. Nick is also a co-founder and CEO of Endo Axiom. Endo is focused on the prevention of autoimmune diseases and improving the quality of life of diabetics.
Disclosure information not submitted.
Oral nanotherapeutics for precision targeting of antigen presenting cells in type 1 diabetes
Tuesday, July 15, 2025
3:05 PM – 3:16 PM EDT